These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36975857)

  • 1. Appropriateness of Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis.
    Liu Y; Chen Y; Chang Z; Han Y; Tang S; Zhao Y; Fu J; Liu Y; Fan Z
    J Cardiovasc Dev Dis; 2023 Feb; 10(3):. PubMed ID: 36975857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Use and Appropriateness of Coronary Interventions for Chronic Total Occlusion (from a Japanese Multicenter Registry).
    Inohara T; Kohsaka S; Miyata H; Ueda I; Hayashida K; Maekawa Y; Kawamura A; Numasawa Y; Suzuki M; Noma S; Nishi Y; Fukuda K
    Am J Cardiol; 2015 Sep; 116(6):858-64. PubMed ID: 26183792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.
    Desai NR; Bradley SM; Parzynski CS; Nallamothu BK; Chan PS; Spertus JA; Patel MR; Ader J; Soufer A; Krumholz HM; Curtis JP
    JAMA; 2015 Nov; 314(19):2045-53. PubMed ID: 26551163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015.
    Hess PL; Kini V; Liu W; Roldan P; Autruong P; Grunwald GK; O'Donnell C; Doll JA; Ho PM; Bradley SM
    JAMA Netw Open; 2020 Apr; 3(4):e203144. PubMed ID: 32315067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria.
    Hannan EL; Samadashvili Z; Cozzens K; Gesten F; Osinaga A; Fish DG; Donahue CL; Bass RJ; Walford G; Jacobs AK; Venditti FJ; Stamato NJ; Berger PB; Sharma S; King SB
    J Am Coll Cardiol; 2017 Mar; 69(10):1234-1242. PubMed ID: 28279289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme - A tertiary centre experience from Western India.
    Patil D; Lanjewar C; Vaggar G; Bhargava J; Sabnis G; Pahwa J; Phatarpekar A; Shah H; Kerkar P
    Indian Heart J; 2017; 69(5):600-606. PubMed ID: 29054183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriateness of percutaneous coronary intervention.
    Chan PS; Patel MR; Klein LW; Krone RJ; Dehmer GJ; Kennedy K; Nallamothu BK; Weaver WD; Masoudi FA; Rumsfeld JS; Brindis RG; Spertus JA
    JAMA; 2011 Jul; 306(1):53-61. PubMed ID: 21730241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a real-time appropriate use criteria decision support application for percutaneous coronary interventions in non-acute coronary syndrome.
    Chen SH; Ho KK; Gannon SA; Thyagarajan B; Chakrabarti AK; Potter BJ; Singla A; Piccirillo BJ; Meduri CU; Cutlip DE
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):E74-9. PubMed ID: 26699241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program.
    Bradley SM; Bohn CM; Malenka DJ; Graham MM; Bryson CL; McCabe JM; Curtis JP; Lambert-Kerzner A; Maynard C
    Circulation; 2015 Jul; 132(1):20-6. PubMed ID: 26022910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Coded Indications for Percutaneous Coronary Interventions in Medicare and the Veterans Affairs After Implementation of Hospital-Level Reporting of Appropriate Use Criteria.
    Dayoub EJ; Nathan AS; Khatana SAM; Wadhera RK; Kolansky DM; Yeh RW; Giri J; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2021 Apr; 14(4):e006887. PubMed ID: 33719490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness ratings of percutaneous coronary intervention in Japan and its association with the trend of noninvasive testing.
    Inohara T; Kohsaka S; Miyata H; Ueda I; Ishikawa S; Ohki T; Nishi Y; Hayashida K; Maekawa Y; Kawamura A; Higashi T; Fukuda K
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1000-9. PubMed ID: 25234672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness Ratings.
    Hannan EL; Samadashvili Z; Cozzens K; Berger PB; Chikwe J; Jacobs AK; Walford G; Ling FSK; Venditti FJ; Gold J; King SB
    JACC Cardiovasc Interv; 2018 Mar; 11(5):473-478. PubMed ID: 29519380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Coronary Intervention Utilization and Appropriateness across the United States.
    Thomas MP; Parzynski CS; Curtis JP; Seth M; Nallamothu BK; Chan PS; Spertus JA; Patel MR; Bradley SM; Gurm HS
    PLoS One; 2015; 10(9):e0138251. PubMed ID: 26379053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriateness of percutaneous coronary interventions in Washington State.
    Bradley SM; Maynard C; Bryson CL
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):445-53. PubMed ID: 22570356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of percutaneous coronary interventions performed according to the appropriate use criteria for coronary revascularization.
    Barbash IM; Dvir D; Torguson R; Xue Z; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2013; 14(6):316-20. PubMed ID: 23988721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omission of Heart Transplant Recipients From the Appropriate Use Criteria for Revascularization and the Ramifications on Heart Transplant Centers.
    Xie JX; Kobashigawa JA; Kennedy KF; Henry TD; Tabak SW; Krebbs R; Shaw L; Abbott JD; Book W; Rab ST; Spertus JA; Goyal A
    JAMA Cardiol; 2020 Jun; 5(6):669-676. PubMed ID: 32267466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDR.
    Bradley SM; Chan PS; Spertus JA; Kennedy KF; Douglas PS; Patel MR; Anderson HV; Ting HH; Rumsfeld JS; Nallamothu BK
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):290-7. PubMed ID: 22576845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of reattempted percutaneous coronary intervention strategy for chronic total occlusion after prior failed procedures: Analysis of the Japanese CTO-PCI Expert Registry.
    Sekiguchi M; Muramatsu T; Kishi K; Muto M; Oikawa Y; Kawasaki T; Fujita T; Hamazaki Y; Okada H; Tsuchikane E
    Catheter Cardiovasc Interv; 2019 Oct; 94(4):516-524. PubMed ID: 31062477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the Appropriate Use Criteria for Coronary Revascularization in Patients with Acute Coronary Syndrome in the Russian Federation: Data from the Federal Registry.
    Popova YV; Kiselev AR; Sagaydak OV; Posnenkova OM; Gridnev VI; Oshchepkova EV
    Eurasian J Med; 2021 Jun; 53(2):96-101. PubMed ID: 34177290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Trends, and Outcomes of Higher-Risk Percutaneous Coronary Interventions Among Patients Without Acute Coronary Syndromes.
    Iverson A; Stanberry LI; Tajti P; Garberich R; Antos A; Burke MN; Chavez I; Gössl M; Henry TD; Lips D; Mooney M; Poulose A; Sorajja P; Traverse J; Wang Y; Bradley S; Brilakis ES
    Cardiovasc Revasc Med; 2019 Apr; 20(4):289-292. PubMed ID: 30054257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.